- Use of cleaning agents at home and respiratory and allergic symptoms in adolescents: The PIAMA birth cohort study
- Endobronchial valves for severe emphysema
- An updated patent review on P-glycoprotein inhibitors (2011-2018).
- Dynamic System Perspectives on Anxiety and Depression
- Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
- Histone Deacetylase Inhibitors Sensitize TRAIL-Induced Apoptosis in Colon Cancer Cells
- Optimal Sampling Strategies for Therapeutic Drug Monitoring of First-Line Tuberculosis Drugs in Patients with Tuberculosis
- Adipose tissue-derived ECM hydrogels and their use as 3D culture scaffold
- Harmonizing scientific rigor with political urgency: policy learnings for identifying accelerators for scale-up from the safe childbirth checklist programme in Rajasthan, India
- A systematic review and meta-analysis of microbial contamination of parenteral medication prepared in a clinical versus pharmacy environment
Most Used Journals
Bio-inspired pulmonary surfactant-modified nanogels: a promising siRNA delivery system.
J Control Release. 2015 Mar 16;
Authors: De Backer L, Braeckmans K, Stuart MC, Demeester J, De Smedt SC, Raemdonck K
Inhalation therapy with small interfering RNA (siRNA) is a promising approach in the treatment of pulmonary disorders. However, clinical translation is severely limited by the lack of suitable delivery platforms. In this study, we aim to address this limitation by designing a novel bioinspired hybrid nanoparticle with a core-shell nanoarchitecture, consisting of a siRNA-loaded dextran nanogel (siNG) core and a pulmonary surfactant (Curosurf®) outer shell. The decoration of siNGs with a surfactant shell enhances the colloidal stability and prevents siRNA release in the presence of competing polyanions, which are abundantly present in biofluids. Additionally, the impact of the surfactant shell on the biological efficacy of the siNGs is determined in lung cancer cells. The presence of the surfactants substantially reduces the cellular uptake of siNGs. Remarkably, the lowered intracellular dose does not impede the gene silencing effect, suggesting a crucial role of the pulmonary surfactant in the intracellular processing of the nanoparticles. In order to surmount the observed reduction in cellular dose, folate is incorporated as a targeting ligand in the pulmonary surfactant shell to incite receptor-mediated endocytosis. The latter substantially enhances both cellular uptake and gene silencing potential, achieving efficient knockdown at siRNA concentrations in the low nanomolar range.
PMID: 25791835 [PubMed – as supplied by publisher]